factor IX -> factor IXa + factor IX activation peptide (kallikrein catalyst)

Stable Identifier
R-HSA-9936467
Type
Reaction [transition]
Species
Homo sapiens
Compartment
Synonyms
activation of factor IX (kallikrein catalyst)
ReviewStatus
5/5
Locations in the PathwayBrowser
General
SVG |   | PPTX  | SBGN
Click the image above or here to open this reaction in the Pathway Browser
The layout of this reaction may differ from that in the pathway view due to the constraints in pathway layout
Activation of FIX involves the cleavage of two peptide bonds: at Arg191 (R191-A192, the α-cleavage) and at Arg226 (R226-V227, the β-cleavage), releasing an activation peptide (A192-R226). The activation peptide has no known function. Activated FIXa consists of an N-terminal light chain (47-191) and a C-terminal heavy chain (227-461), which are linked by a disulfide bond between Cys178 and Cys335 (Di Scipio RG et al., 1978; Zögg T & Brandstetter H, 2009).

FIX can be cleaved by tissue factor (TF)-bound factor VIIa (FVIIa) during the initiation phase of coagulation and by FXIa during the amplification phase (Komiyama Y et al., 1990; Gailani D et al., 2014). Additionally, plasma kallikrein (PKa) can cleave FIX during the FXIIa-mediated activation of the kallikrein-kinin system (Visser M et al., 2020; Noubouossie DF et al., 2020; Kearney KJ et al., 2021). FXI and prekallikrein (PK) share high sequence homology due to gene duplication (Ponczek MB et al., 2020). Both proteins circulate bound to high-molecular-weight kininogen (HK) and can be activated by FXIIa (Cheng Q et al., 2010; Li C et al., 2023; Mohammed BM et al., 2024).

Despite their similarities, the mechanism of FIX activation by PKa differs from that of FXIa. Unlike FXIa, PKa activates FIX in a manner independent of calcium and phospholipids (Kearney KJ et al., 2021). Structural studies have revealed differences between PKa and FXIa that may influence their interactions with substrates (Li C et al., 2019). Although FXIa is more catalytically efficient than PKa in activating FIX, the higher plasma concentration of prekallikrein (PK) suggests that PKa could have a significant role under physiological conditions (Kearney KJ et al., 2021).

In vivo, PKa-mediated FIX activation has been observed in FXI-deficient mice following FXII activation by agents such as ellagic acid or polyphosphates (Visser M et al., 2020). Furthermore, PKa-mediated FIX activation may contribute to thrombin generation and clot formation in human pathologies involving FXII activation.

This Reactome event shows the PKa-catalyzed cleavage of FIX at Arg191 and Arg226.

Literature References
PubMed ID Title Journal Year
31766871 Plasma Kallikrein Contributes to Coagulation in the Absence of Factor XI by Activating Factor IX

Visser, M, van Oerle, R, ten Cate, H, Laux, V, Mackman, N, Heitmeier, S, Spronk, HMH

Arterioscler Thromb Vasc Biol 2020
33397811 Kallikrein directly interacts with and activates Factor IX, resulting in thrombin generation and fibrin formation independent of Factor XI

Kearney, KJ, Butler, J, Posada, OM, Wilson, C, Heal, S, Ali, M, Hardy, L, Ahnström, J, Gailani, D, Foster, R, Hethershaw, E, Longstaff, C, Philippou, H

Proc Natl Acad Sci U S A 2021
Participants
Participates
Catalyst Activity

serine-type endopeptidase activity of Plasma kallikrein [extracellular region]

Orthologous Events
Authored
Reviewed
Created
Cite Us!